摘要
Multiple Sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system, causing increased vulnerability to infections and disability among young adults. Ever since the coronavirus disease 2019 (COVID-19) outbreak, caused by severe acute respiratory syndrome coronavirus 2 infections, there have been concerns among people with MS (PwMS) about the potential interactions between various disease-modifying therapies and COVID-19. The COVID-19 in MS Global Data Sharing Initiative (GDSI) was initiated in 2020 to address these concerns. This paper focuses on the anonymisation and open-sourcing of a GDSI sub-dataset, comprising dat
条目元信息
- 资源编号
- AISLI-R-DBAD3EB2FB552DC70F98
- 类型
- 数据集
- 来源目录
- registry.opendata.aws
- 主题领域
- 生命科学与生物医学
- 使用条件
- Creative Commons Attribution 4.0 International Public License